Background A microorganism is a complex biological system able to preserve its functional features against external perturbations and the ability of the living systems to oppose to these external perturbations is defined “robustness”. The antibiotic resistance, developed by different bacteria strains, is a clear example of robustness and of ability of the bacterial system to acquire a particular functional behaviour in response to environmental changes. In this work we have modeled the whole mechanism essential to the methicillin-resistance through a systems biology approach. The methicillin is a β-lactamic antibiotic that act by inhibiting the penicillin-binding proteins (PBPs). These PBPs are involved in the synthesis of peptidoglycans, essential mesh-like polymers that surround cellular enzymes and are crucial for the bacterium survival. Methodology The network of genes, mRNA, proteins and metabolites was created using CellDesigner program and the data of molecular interactions are stored in Systems Biology Markup Language (SBML). To simulate the dynamic behaviour of this biochemical network, the kinetic equations were associated with each reaction. Conclusions Our model simulates the mechanism of the inactivation of the PBP by methicillin, as well as the expression of PBP2a isoform, the regulation of the SCCmec elements (SCC: staphylococcal cassette chromosome) and the synthesis of peptidoglycan by PBP2a. The obtained results by our integrated approach show that the model describes correctly the whole phenomenon of the methicillin resistance and is able to respond to the external perturbations in the same way of the real cell. Therefore, this model can be useful to develop new therapeutic approaches for the methicillin control and to understand the general mechanism regarding the cellular resistance to some antibiotics.
References
[1]
Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111: 1265–1273.
[2]
Savic M, Ilic-Tomic T, Macmaster R, Vasiljevic B, Conn GL (2008) Critical Residues for Cofactor Binding and Catalytic Activity in the Aminoglycoside Resistance Methyltransferase Sgm. J Bacteriol 190: 5855–61.
[3]
Lehar J, Krueger A, Zimmermann G, Borisy A (2008) High-order combination effects and biological robustness. Mol Syst Biol 4: 215.
[4]
Brasch MA, Hartley JL, Vidal M (2004) ORFeome cloning and systems biology: standardized mass production of the parts from the parts-list. Genome Res 14: 2001–9.
[5]
Costantini S, Autiero I, Colonna G (2008) On new challenge for the Bioinformatics. Bioinformation 3: 238–239.
[6]
Ahn AC, Tewari M, Poon CS, Phillips RS (2006) The limits of reductionism in medicine: Could systems biology offer an alternative? PLoS Med 3: e208.
[7]
Sheehy JE, Gunawardana D, Ferrer AB, Danila F, Tan KG, Mitchell PL (2008) Systems biology or the biology of systems: routes to reducing hunger. New Phytol 179: 579–82.
[8]
Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF (2001) A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci. Science 291: 1962–5.
[9]
Chambers HF, Sachdeva MJ, Hackbarth CJ (1994) Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. Biochem J 301: 139–44.
[10]
Stapleton PD, Taylor PW (2002) Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog 85: 57–72.
[11]
Gordon RJ, Lowy FD (2008) Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46: Suppl 5S350–9.
[12]
Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H, European Antimicrobial Resistance Surveillance System Participants (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10: 1627–1634.
[13]
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR (1999) Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340: 493–501.
[14]
Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC (2003) Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001. Clin Infect Dis 36: 429–439.
[15]
Haley RW, Cushion NB, Tenover FC, Bannerman TL, Dryer D, Ross J, Sánchez PJ, Siegel JD (1995) Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 171: 614–24.
[16]
Rehm SJ (2008) Staphylococcus aureus: the new adventures of a legendary pathogen. Cleve Clin J Med 75: 177–80, 183–6, 190–2.
[17]
Bonten MJ, Austin DJ, Lipsitch M (2001) Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis 33: 1739–46.
[18]
Olsen RJ, Burns KM, Chen L, Kreiswirth BN, Musser JM (2008) Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 46: 1144–7.
[19]
O'Hara FP, Guex N, Word JM, Miller LA, Becker JA, Walsh SL, Scangarella NE, West JM, Shawar RM, Amrine-Madsen H (2008) A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus. J Infect Dis 197: 187–94.
[20]
Regoes RR, Wiuff C, Zappala RM, Garner KN, Baquero F, Levin BR (2004) Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob Agents Chemother 48: 3670–6.
[21]
Brandner CJ, Maier RH, Henderson DS, Hintner H, Bauer JW, Onder K (2008) The ORFeome of Staphylococcus aureus v 1.1. BMC Genomics 9: 321.
[22]
Murphy JT, Walshe R, Devocelle M (2008) A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA). J Theor Biol 254(2): 284–93.
[23]
Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, Jamklang M, Chavalit T, Song JH, Hiramatsu K (2006) Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 50: 1001–12.
[24]
Golemi-Kotra D, Cha JY, Meroueh SO, Vakulenko SB, Mobashery S (2003) Resistance to β-Lactam Antibiotics and Its Mediation by the Sensor Domain of the Transmembrane BlaR Signaling Pathway in Staphylococcus aureus. J Biol Chem 278: 18419–18425.
[25]
Giesbrecht P, Kersten T, Maidhof H, Wecke J (1998) Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin. Microbiol Mol Biol Rev 62: 1371–1414.
[26]
Craig WA (1993) Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob Chemother 31: 149–58.
[27]
Zhanel GG, Hoban DJ, Harding GK (1991) The postantibiotic effect: a review of in vitro and in vivo data. DICP 25: 153–63.
[28]
Funahashi A, Tanimura N, Morohashi M, Kitano H (2003) CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 1: 159–162.
[29]
Hucka M, Finney A, Bornstein BJ, Keating M, Shapiro BE, Matthews J, Kovitz BL, Schilstra MJ, Funahashi A, Doyle JC, Kitano H (2004) Evolving a lingua franca and associated software infrastructure for computational systems biology: theSystemsBiologyMarkupLanguage(SBML) project. IEE Systems Biology 1: 41–53.
[30]
Dr？ger A, Hassis N, Supper J, Schr？der A, Zell A (2008) SBMLsqueezer: a CellDesigner plug-in to generate kinetic rate equations for biochemical networks. BMC Syst Biol 2: 39.
[31]
Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H (2003) The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19: 524–531.
